Unexpected NIPT Findings: When the Result Is About the Mother, Not the Baby

Prenatal screening guide · 2026

Most of the cell-free DNA in the sample is the mother’s. Occasionally, that is where the abnormal signal comes from.

By MedEx · Updated September 2026 · Approx. 7-minute read

Quick answer

NIPT sequences a mixture of maternal and placental DNA, and the majority of it is maternal. Occasionally the abnormal pattern detected originates from the mother rather than the pregnancy. Recognised examples include an undiagnosed maternal sex chromosome variation, a maternal copy number variant, DNA from a previous transplant or transfusion, and — rarely but importantly — maternal malignancy, which can produce unusual patterns across multiple chromosomes. These findings are uncommon, but they are a recognised part of NIPT and worth understanding before testing.

In this guide

1. Why maternal findings arise
2. The recognised categories
3. The malignancy question, handled carefully
4. What this means for consent

Why maternal findings arise

Cell-free DNA in a pregnant woman’s blood is predominantly her own, with a minority from the placenta. The analysis assumes the maternal contribution is chromosomally unremarkable and looks for deviations attributed to the pregnancy.

When that assumption does not hold — because the mother herself carries a chromosomal variation, or because another source of DNA is present — the deviation can be misattributed. This is not a malfunction; it is a consequence of what the test is analysing.

The commonest scenario is an undiagnosed maternal sex chromosome variation, such as mosaic 45,X or 47,XXX. Many people with these carry them without ever knowing, and NIPT may be the first time it surfaces.

The recognised categories

Some of these are avoidable sources of confusion. Disclose transplant, transfusion and immunotherapy history when booking through the MedEx NIPT service.

The malignancy question, handled carefully

This is the finding that causes the most alarm, so it deserves a proportionate description. It is rare. Most abnormal NIPT results have nothing to do with maternal health, and the great majority relate to the placenta or fetus.

The pattern that raises the possibility is distinctive: abnormalities involving multiple chromosomes at once, rather than a single chromosome, particularly when subsequent diagnostic testing shows the fetus is unaffected. Laboratories may flag such a pattern and recommend maternal assessment.

If that happens, the appropriate response is structured evaluation with a specialist — not immediate alarm and not dismissal. Many such investigations find nothing. Where something is found, detection at this stage is generally earlier than it would otherwise have been.

Arrange assessment through a specialist teleconsultation or a doctor consultation rather than trying to interpret the pattern yourself.

What this means for consent

The possibility of maternal findings is a genuine part of informed consent that is frequently omitted from marketing material. Before testing, it is worth knowing:

1. That maternal findings are possible, even though they are uncommon.
2. Whether you want to be told. Some people would prefer to know about an incidental finding relating to their own health; others would not. Laboratory and clinic policies on disclosure differ.
3. What follow-up would involve, so an unexpected recommendation is not a shock.
4. That most abnormal results are not about you. Keeping the base rates in mind is the best defence against disproportionate worry.

These are exactly the questions a pre-test conversation is for. It takes a few minutes and materially changes how an unexpected result lands — book a doctor consultation before the draw, and see the broader prenatal testing pathway guide.

Frequently asked questions

Can NIPT find something about the mother rather than the baby?

Yes, though it is uncommon. Because most cell-free DNA in the sample is maternal, an abnormal pattern can originate from the mother – most often an undiagnosed sex chromosome variation or a copy number variant.

Can NIPT detect cancer in the mother?

Rarely, tumour DNA can produce abnormal patterns across multiple chromosomes simultaneously, which is the characteristic signature. This is uncommon, and most abnormal results have nothing to do with maternal health.

Why does a previous transplant matter?

An organ or bone marrow transplant introduces donor DNA into the circulation, which can include Y chromosome material in a female recipient and complicate interpretation. Disclose it when booking.

Does a recent blood transfusion affect NIPT?

It can, by temporarily introducing donor DNA. Tell the laboratory if you have had a recent transfusion.

Will I be told about an incidental maternal finding?

Policies on disclosure differ between laboratories and clinics. It is worth deciding what you would want and asking about the policy before testing.

How common are maternal incidental findings?

Uncommon. The great majority of abnormal NIPT results relate to the placenta or the fetus rather than to maternal health.

Sources and further reading

1. ACMG: Noninvasive prenatal screening practice resource
2. ISPD position statement on cell-free DNA screening
3. MedEx NIPT service

Medical disclaimer: This article is general health information and does not replace medical advice, diagnosis or treatment. Laboratory reference ranges differ between laboratories and results must be interpreted alongside your symptoms, medicines and medical history. Speak with a qualified clinician before starting, stopping or changing any treatment. Service details, inclusions and prices can change — confirm them with MedEx before booking.